129 related articles for article (PubMed ID: 38052342)
1. Daptomycin non-susceptible Staphylococcus argenteus isolated from a patient without prior antibiotic exposure.
Lim C; Mowlaboccus S; Daley DA; Shoby P; Coombs GW
Int J Antimicrob Agents; 2024 Feb; 63(2):107046. PubMed ID: 38052342
[No Abstract] [Full Text] [Related]
2. Case Commentary: Daptomycin Resistance in Staphylococcus argenteus-from Northern Australia to San Francisco.
Bayer AS; Tong SYC
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32718962
[No Abstract] [Full Text] [Related]
3. Genomic Profiling of Evolving Daptomycin Resistance in a Patient with Recurrent Staphylococcus argenteus Sepsis.
Hao S; Abdelghany M; Lyden A; Sit R; Tan M; Tato CM; DeRisi JL; Miller S; Doernberg SB; Langelier C
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32601156
[No Abstract] [Full Text] [Related]
4. Daptomycin non-susceptible Staphylococcus aureus at a US medical centre.
Velazquez A; DeRyke CA; Goering R; Hoover V; Wallace MR
Clin Microbiol Infect; 2013 Dec; 19(12):1169-72. PubMed ID: 23480569
[TBL] [Abstract][Full Text] [Related]
5. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.
Skiest DJ
J Clin Microbiol; 2006 Feb; 44(2):655-6. PubMed ID: 16455939
[TBL] [Abstract][Full Text] [Related]
6. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
Dortet L; Anguel N; Fortineau N; Richard C; Nordmann P
Int J Infect Dis; 2013 Nov; 17(11):e1076-7. PubMed ID: 23578850
[TBL] [Abstract][Full Text] [Related]
7. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
Golden M; Shaib W; Havill N
Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108
[No Abstract] [Full Text] [Related]
8. Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
Mariani PG; Sader HS; Jones RN
J Antimicrob Chemother; 2006 Aug; 58(2):481-3. PubMed ID: 16847029
[No Abstract] [Full Text] [Related]
9. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.
Moise PA; North D; Steenbergen JN; Sakoulas G
Lancet Infect Dis; 2009 Oct; 9(10):617-24. PubMed ID: 19778764
[TBL] [Abstract][Full Text] [Related]
11. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
Kelley PG; Gao W; Ward PB; Howden BP
J Antimicrob Chemother; 2011 May; 66(5):1057-60. PubMed ID: 21393156
[TBL] [Abstract][Full Text] [Related]
12. EUCAST Technical Note on daptomycin.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Clin Microbiol Infect; 2006 Jun; 12(6):599-601. PubMed ID: 16700717
[No Abstract] [Full Text] [Related]
13. Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
Karau MJ; Schmidt-Malan SM; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722889
[No Abstract] [Full Text] [Related]
14. Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
Gqada Z; Marais B; Wasserman E; Bamford C; Orth H; Sakoulas G; Rose W; Rybak MJ; Pillai S; Alder J; Moellering RC; Eliopoulos GM
J Clin Microbiol; 2008 Jul; 46(7):2471; author reply 2471-2. PubMed ID: 18614667
[No Abstract] [Full Text] [Related]
15. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin-resistant Staphylococcus pettenkoferi of human origin.
Savini V; Kosecka M; Siegwart E; Marrollo R; Polilli E; Palmieri D; Fazii P; Carretto E; Międzobrodzki J; Bukowski M
Acta Biochim Pol; 2016; 63(2):297-301. PubMed ID: 26730410
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
Sakoulas G; Rose W; Rybak MJ; Pillai S; Alder J; Moellering RC; Eliopoulos GM
J Clin Microbiol; 2008 Jan; 46(1):220-4. PubMed ID: 18003803
[TBL] [Abstract][Full Text] [Related]
18. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
Alder J
Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections.
Van Praagh AD; Li T; Zhang S; Arya A; Chen L; Zhang XX; Bertolami S; Mortin LI
Antimicrob Agents Chemother; 2011 Sep; 55(9):4081-9. PubMed ID: 21709082
[TBL] [Abstract][Full Text] [Related]
20. Human serum triggers antibiotic tolerance in Staphylococcus aureus.
Ledger EVK; Mesnage S; Edwards AM
Nat Commun; 2022 Apr; 13(1):2041. PubMed ID: 35440121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
